Gene transfer: a review of methods and applications

HM Prince - Pathology, 1998 - Taylor & Francis
Gene transfer is a potentially powerful tool for the treatment of a wide variety of diseases.
The transfer of these genes is achleved by utilizing a variety of vectors, including retroviral …

An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo

CM Lupu, C Eisenbach, MA Kuefner, J Schmidt… - Journal of …, 2006 - Springer
We established an orthotopic animal model of colon cancer in mice and applied this model
to study the antitumor effects of B7–H3, the newest member of the B7 family of costimulatory …

Progress in cancer gene therapy

G Kouraklis - Acta oncologica, 1999 - Taylor & Francis
Many technical difficulties have to be overcome before effective gene therapy can be
achieved. Strategies for gene therapy include'suicide'gene therapy, transfer of a tumor …

Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer …

PCR Emtage, Y Wan, M Hitt, FL Graham… - Human Gene …, 1999 - liebertpub.com
We have previously demonstrated that intratumoral injection with Ad vectors expressing IL-2
or IL-12 can induce regression in a murine breast cancer model. These IL-2-or IL-12 …

A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast …

PCR Emtage, Y Wan, JL Bramson… - The Journal of …, 1998 - journals.aai.org
Tumors that express tumor-specific antigens can maintain growth in an immunocompetent
organism. Current hypotheses tend toward T cell anergy as a key component for the …

Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte–macrophage colony-stimulating factor induces a local antitumour response …

H Chong, S Todryk, G Hutchinson, IR Hart, RG Vile - Gene therapy, 1998 - nature.com
Previously, we showed that expression of B7–1 in CMT93 murine colorectal tumour cells
inhibited their growth in immunocompetent animals. However, this did not result in any …

Vaccine effect of granulocyte–macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement …

Y Nakazaki, K Tani, ZT Lin, H Sumimoto, H Hibino… - Gene therapy, 1998 - nature.com
To develop immunogene therapy targeting minimal residual hematopoietic tumor cells in
patients, we transduced murine GM-CSF or CD80 gene into murine WEHI 3B …

Cytokine gene transduction in the immunotherapy of cancer

G Parmiani, MP Colombo, C Melani, F Arienti - Advances in Pharmacology, 1997 - Elsevier
Publisher Summary Cytokines include heterogeneous groups of glycoproteins that act
locally in minute concentrations to mediate intercellular relationships by either activating or …

Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model …

R Stripecke, DC Skelton, PK Pattengale… - Human gene …, 1999 - liebertpub.com
Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is a highly
aggressive malignancy caused by the bcr-abl translocation oncogene. To explore …

Adenoviral delivery of B7–1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells

MG Gilligan, P Knox, S Weedon, R Barton, DJ Kerr… - Gene therapy, 1998 - nature.com
The majority of tumour cells do not express immune costimulatory molecules and this may
account for their inability to stimulate directly an antitumour T cell response. Here we report …